In Vivo Survival of Mesenchymal Stromal Cell–Enhanced Decellularized Nerve Grafts for Segmental Peripheral Nerve Reconstruction

2019 ◽  
Vol 44 (6) ◽  
pp. 514.e1-514.e11 ◽  
Author(s):  
Nadia Rbia ◽  
Liselotte F. Bulstra ◽  
Roman Thaler ◽  
Steven E.R. Hovius ◽  
Andre J. van Wijnen ◽  
...  
Bone Reports ◽  
2020 ◽  
Vol 13 ◽  
pp. 100509
Author(s):  
Alasdair G. Kay ◽  
James Fox ◽  
Andrew Stone ◽  
Sally James ◽  
Elizabeth Kapasa ◽  
...  

Cytotherapy ◽  
2013 ◽  
Vol 15 (12) ◽  
pp. 1484-1497 ◽  
Author(s):  
Wayne Y.W. Lee ◽  
Ting Zhang ◽  
Carol P.Y. Lau ◽  
C.C. Wang ◽  
Kai-Ming Chan ◽  
...  

2014 ◽  
Vol 2 (8) ◽  
pp. e201 ◽  
Author(s):  
Srikanth Vasudevan ◽  
Jiying Huang ◽  
Barry Botterman ◽  
Hani S. Matloub ◽  
Edward Keefer ◽  
...  

2014 ◽  
Vol 22 (10) ◽  
pp. 1864-1871 ◽  
Author(s):  
Nobuko Tano ◽  
Takuya Narita ◽  
Masahiro Kaneko ◽  
Chiho Ikebe ◽  
Steven R Coppen ◽  
...  

2017 ◽  
Vol 10 (1) ◽  
pp. 83-92 ◽  
Author(s):  
Diego Noe Rodriguez Sanchez ◽  
Matheus Bertanha ◽  
Thiago Dias Fernandes ◽  
Luiz Antônio de Lima Resende ◽  
Elenice Deffune ◽  
...  

2010 ◽  
Vol 31 (3) ◽  
pp. 365-375 ◽  
Author(s):  
Qiang Xu ◽  
Hong-Tian Zhang ◽  
Ke Liu ◽  
Jun-Hua Rao ◽  
Xiao-Ming Liu ◽  
...  

2021 ◽  
Author(s):  
Louis J Born ◽  
Shannon T McLoughlin ◽  
Dipankar Dutta ◽  
Bhushan Mahadik ◽  
Xiaofeng Jia ◽  
...  

Extracellular vesicles (EVs) represent an emerging class of therapeutics with significant potential and broad applicability. However, a general limitation is their rapid clearance after administration. Thus, methods to enable sustained EV release are of great potential value. Here, we demonstrate that EVs from mesenchymal stem/stromal cells (MSCs) can be incorporated into 3D-printed gelatin methacrylate (GelMA) hydrogel bioink, and that the initial burst release of EVs can be reduced by increasing the concentration of crosslinker during gelation. Further, the data show that MSC EV bioactivity in an endothelial gap closure assay is retained after the 3D printing and photocrosslinking processes. Our group previously showed that MSC EV bioactivity in this assay correlates with pro-angiogenic bioactivity in vivo, thus these results indicate therapeutic potential of MSC EV-laden GelMA bioinks.


2000 ◽  
Vol 191 (4) ◽  
pp. S80-S81
Author(s):  
Steven C. Haase ◽  
Paul S. Cederna ◽  
Robert G. Dennis ◽  
William M. Kuzon

Sign in / Sign up

Export Citation Format

Share Document